Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted and appeared in  DietType 2 DiabetesPreventionIssue 583

Onion Skins Help Reduce Diabetes Risk

According to the results of a new study, onion skins have now joined the list of things that could offer potential benefits for people with type 2 diabetes. The study, at the University of Madrid found that the brown skin and external layers of onions contain useful amounts of fiber and flavonoids, and that the bulbs contain sulphurous compounds and fructans. The research showed that because the brown skin of the onion was high in dietary fiber it could be used as a functional ingredient, and that two outer fleshy layers also contain flavonoids, and have a high antioxidant capacity. Onion waste could be used as a natural source of ingredients with high functional value, because this vegetable is rich in compounds that provide benefits for human health. Plant Foods for Human Nutrition July 2011

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 20 July, 2011 and appeared in  DietType 2 DiabetesPreventionIssue 583

Past five issues: Issue 779 | SGLT-2 Inhibitors Special Edition April 2015 | Diabetes Clinical Mastery Series Issue 238 | Issue 778 | Diabetes Clinical Mastery Series Issue 237 |

2015 Most Popular Articles:

Glyburide Used for Gestational Diabetes May Increase Risk of Birth Complications
Posted April 02, 2015
A Potential New Type 2 Diabetes Indicator
Posted April 02, 2015
A Third Treatment Option in Uncontrolled Type 2 Diabetes
Posted April 02, 2015
FDA Panel Recommends New CV Safety Warnings on Onglyza and Nesina DPP-4s
Posted April 17, 2015
Gastric Electrical Stimulation an Alternative to Insulin Injections?
Posted April 02, 2015
Women Retain Insulin Sensitivity Better than Men
Posted April 02, 2015
A Novel Scale May Indicate Glycemic Progression to Type 1 Diabetes
Posted April 02, 2015
Artificial Pancreas Software Algorithm Receives Approval in Europe
Posted April 02, 2015
HbA1c and OGTT Performance in Prediabetic Obese Adolescents
Posted April 02, 2015
Combination of a DPP-4 and an SGLT-2 for Type 2’s
Posted April 10, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Would you like to see more CE on the newest drugs for diabetes?
CME/CE of the Week
NEW! How Do We Optimize with Antiplatelet and Anticoagulant Therapies? 
from the Acute Coronary Education Summit - July 27-28, 2011

Category: Cardiology
Time: 240 minutes



Search Articles On Diabetes In Control